Who said what in PhRMA's $80B deal?

PhRMA may be tired of talking about its $80 billion deal for healthcare reform, but if you're not tired of reading about it, check out Marc Ambinder's behind-the-scenes look at negotiations between the pharma lobby, Congress and the White House. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.